Minimal clinically important difference of Ibadan knee hip osteoarthritis outcome measure (IKHOAM) a cross-sectional study

Journal of Physical Therapy

Volumn 3, Issue 2, 2011, Pages 52-60

  Akinpelu, Aderonke Omobonike ^a   Odole, Adesola Christiana ^a   Raheem, Sarafadeen ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Minimum clinically important difference; Osteoarthritis; Outcome measurement; Physical examination; Responsiveness

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE DURATION; FEMALE; HIP OSTEOARTHRITIS; HUMAN; IBADAN KNEE HIP OSTEOARTHRITIS OUTCOME MEASURE; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PREDICTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT; TREATMENT DURATION;

EID: 84857489308     PISSN: 20790015     EISSN: 20799209     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cook CE. Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretence: JManual Manipulative Ther.2008;16(4):83.
2. Guyatt GH, Walter S, Norman GR. Measuring change over time:Assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40:171-8.
3. Hsieh YW, Wang CU, Wu SC, Chen PC, Sheu CF, Hsieh CL. Establishing the Minimal Clinically Important Difference of the Barthel Index in Stroke Patients. Neurorehabil Neural Repair. 2007;21:233.
4. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14:109-14.
5. Brealey S. Measuring patient health status in rheumatoid arthritis-what is a minimal clinically important difference?JRheumatol.2004;31:1026-8.
6. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol.1994;47:81-7.
7. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-44.
8. Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH. How much is enough and who says so? BJOG. 2004;111:605-12.
9. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials. 1989;10:407-15.
10. Wright JG. The minimal important difference: Who's to say what is important? J Clin Epidemiol. 1996;49:1221-2.
11. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res. 1993;2:221-6.
12. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395-407.
13. Cohen, J. Statistical power analysis for the behavioural sciences (2nd Ed.). 1988; Hillsdale, NJ: Lawrence Erlbaum.
14. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials. 1991;12(4 Suppl):142S-58S.
15. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27:178-89.
16. Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH. How much is enough and who says so? BJOG. 1989;111:605-12.
17. Sloan J, Vargas-Chanes D, Kamath C, Sargent D, Novotny P, Atherton P, et al. Detecting worms, ducks and elephants: A simple approach for defining clinically relevant effects in quality-of-life measures. J Cancer Integr Med. 2003;1:41-7.
18. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52:861-73.
19. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37:469-78.
20. Guyatt GH, Walter S, Norman GR. Measuring change over time:Assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40:171-8.
21. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psych. 1991;59:12-9.
22. Jordan K, Dunn KM, Lewis M, Croft P. A minimal clinically important difference was derived for the Roland-Morris Disability Questionnaire for low back pain. J Clin Epidemiol. 2006;59:45-52.
23. Nunnally J, Bernstein I. Psychometric Theory. 1994; New York, NY: McGraw Hill.
24. Yost KJ, Eton DT. Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences: The FACIT Experience. Eval Health Profess. 2005;28:172.
25. Akinpelu AO, Odole AC, Adegoke BOA, Adeniyi AF. Development and initial validation of Ibadan Knee/Hip Osteoarthritis Outcome measure (IKHOAM). South Afr J Physiother 2007;63:3-8.
26. Akinpelu AO, Alonge TO, Adekanla BA, Odole AC. Prevalence and Pattern of symptomatic knee OA in Nigeria: A community based study. Internet J Allied Health Sci Pract. 2009;7:3(2).
27. Akinpelu AO, Alonge OO, Adekanla BA, Odole AC. Pattern of osteoarthritis seen in physiotherapy facilities in Ibadan and Lagos, Nigeria. Afr J Biomed Res. 2007;10:111-5.
28. Ogunlade SO, Alonge TO, Omololu AB, Adekolujo OS. Clinical Spectrum of large joint Osteoarthritis in Ibadan, Nigeria. Eur J Sci Res. 2005;11:116-22.
29. Odole AC, Akinpelu AO, Bamgboye EA. Validity and internal consistency of a Yoruba version of the Ibadan knee/hip osteoarthritis outcome measure (Yoruba version). Afr J Med Sci. 2006;35:349-57.
30. Odole AC, Akinpelu AO. Validity and internal consistency of Hausa version of the Ibadan knee/hip osteoarthritis outcome measure. Health Qual Life Outcomes.2008;6:86.
31. Altman RD, Asch E, Bloch D, Bole G, Borensten D, Brandt K, Christy W, et al, Development of criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheumat. 1986;23:1039-49.
32. Ebong WW. Osteoarthritis of the knee in Nigerians. Ann Rheum Dis. 1985;44:682-4.
33. Adebajo A. Pattern of osteoarthritis in a West African teaching Hospital. Ann Rheum Dis. 1991;50:20-2.
34. Slemender C, Brandt KD, Heilman DK, Mazzuca S, Braunstein EM, Katz BP, et al. Quadriceps Weakness and Osteoarthritis of the Knee. Ann Intern Med. 1997;127:97-104.
35. Mody G, Woolf A. A report on the global burden musculoskeletal disorders. Business briefing of European Pharmacotherapy Association 2003. http;//www.touchbriefings.com/ Accessed 31/01/11
36. th International Conference of Medical Women's Association. 2003
37. Wilson MG, Michet CJ, Srup DM, Melton IJ. Idiopathic symptomatic Osteoarthritis of the hip and knee; A population based incidence study. Mayo Clin Proc. 1990;60:1214-21.
38. Van Schaardenburg D, Van den Brnde KJS, Ligathart GJ, Breedveld FC, Hazes JMW. Musculoskeletal disorders and disability in persons. aged 85 years and over: a community survey. Ann Rheum Dis. 1994;53:807-11.
39. Eti E, Koukou H, Dabioko JC, Quali B, Quattara B, Gabla KA, et al. Epidemiology and features of knee osteoarthritis in the Ivory Coast. Rev Rheum. 1998;65:770-6.
40. Mannoni A, Briganti MP, Di Bari M, Ferrucci L, Costanzo S, Serni U, et al. Epidemiological profile of symptomatic Osteoarthritis in older adults; A population based study in Dicomano, Italy. Ann Rheum Dis. 2003;62:576-8.
41. Hays RD, Woolley JM. The concept of clinically meaningful difference in healthrelated quality-of-life research: How meaningful is it? Pharmacoeconomics. 2000;18:419-23.
42. Liang MH. Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care. 2000;38:84-90.
43. Angst F, Aeschliman A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45:384-91.
44. Escobar A, Quintana JM, Bilbao A, Arostegui I, Lafuente I, Vidaurretta I. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage. 2007;15:273-80.
45. White DK, Keysor JJ, Lavalley MP, Lewis CE, Torner JC, Nevitt MC, Felson DT. Clinically Important Improvement in Function is common in people with or at High Risk of Knee OA: The MOST Study. J Rheumatol. 2010;37:1244-51.